VIDEO: How proposed patient substance use privacy rule impacts physicians

Health providers have until April 11 to offer perspective on a proposed rule that would loosen restrictions over the redisclosure of patient records involving substance abuse.

The U.S. Department of Health and Human Services in early February announced suggested revisions to the Confidentiality of Alcohol and Drug Abuse Patient Records regulations, known as 42 CFR Part 2. The changes, published Feb. 9 in the Federal Register, aim to facilitate the transfer of health information within new care models while protecting patient privacy.

The proposed rule seeks to broaden the consent process for re-releasing substance use records to make it easier for health information exchanges to obtain health data, Chicago health law attorney Gerald “Jud” DeLoss said at an American Health Lawyers Association (AHLA) meeting.

In this video interview at the AHLA conference, Mr. DeLoss breaks down the proposed modifications and discusses how the rule, if made final, would affect physician practices. He also addresses how the rule would impact the intersection of behavioral health and primary care treatment.

“I think the proposed rule goes a long way in terms of advancing the goals of integrated care between behavioral health and primary care,” Mr. DeLoss said.

agallegos@frontlinemedcom.com

On Twitter @legal_med

Health providers have until April 11 to offer perspective on a proposed rule that would loosen restrictions over the redisclosure of patient records involving substance abuse.

The U.S. Department of Health and Human Services in early February announced suggested revisions to the Confidentiality of Alcohol and Drug Abuse Patient Records regulations, known as 42 CFR Part 2. The changes, published Feb. 9 in the Federal Register, aim to facilitate the transfer of health information within new care models while protecting patient privacy.

The proposed rule seeks to broaden the consent process for re-releasing substance use records to make it easier for health information exchanges to obtain health data, Chicago health law attorney Gerald “Jud” DeLoss said at an American Health Lawyers Association (AHLA) meeting.

In this video interview at the AHLA conference, Mr. DeLoss breaks down the proposed modifications and discusses how the rule, if made final, would affect physician practices. He also addresses how the rule would impact the intersection of behavioral health and primary care treatment.

“I think the proposed rule goes a long way in terms of advancing the goals of integrated care between behavioral health and primary care,” Mr. DeLoss said.

agallegos@frontlinemedcom.com

On Twitter @legal_med

Health providers have until April 11 to offer perspective on a proposed rule that would loosen restrictions over the redisclosure of patient records involving substance abuse.

The U.S. Department of Health and Human Services in early February announced suggested revisions to the Confidentiality of Alcohol and Drug Abuse Patient Records regulations, known as 42 CFR Part 2. The changes, published Feb. 9 in the Federal Register, aim to facilitate the transfer of health information within new care models while protecting patient privacy.

The proposed rule seeks to broaden the consent process for re-releasing substance use records to make it easier for health information exchanges to obtain health data, Chicago health law attorney Gerald “Jud” DeLoss said at an American Health Lawyers Association (AHLA) meeting.

In this video interview at the AHLA conference, Mr. DeLoss breaks down the proposed modifications and discusses how the rule, if made final, would affect physician practices. He also addresses how the rule would impact the intersection of behavioral health and primary care treatment.

“I think the proposed rule goes a long way in terms of advancing the goals of integrated care between behavioral health and primary care,” Mr. DeLoss said.

agallegos@frontlinemedcom.com

On Twitter @legal_med